Rutgers Links 10%-20% Implant Infections to Titanium Particles, Identifies TRPC1 Drug Target
Updated
Updated · ScienceDaily · Oct 23
Rutgers Links 10%-20% Implant Infections to Titanium Particles, Identifies TRPC1 Drug Target
1 articles · Updated · ScienceDaily · Oct 23
Summary
A Rutgers study found peri-implantitis can persist because corroded titanium from dental implants releases microscopic particles that derail immune cells, helping infections resist antibiotics while accelerating jawbone loss.
Human tissue, lab-cell and mouse experiments showed bacteria create acidic biofilms that corrode implants; macrophages exposed to the particles swallowed fewer than half as many bacteria and stayed locked in damaging inflammation.
TRPC1, a calcium channel in macrophages, emerged as the key switch: mice lacking it developed smaller abscesses, produced fewer inflammatory signals and cleared bacteria more effectively.
Peri-implantitis affects an estimated 10% to 20% of implant patients, costs more than $1 billion a year globally, and current antibiotic treatment succeeds in fewer than half of cases.
The findings point to immune-targeted drugs now being evaluated in human cells and reinforce use of nonabrasive implant-cleaning methods, since metal tools can scrape titanium and release additional particles.